In comparison with the control, the expressions of muscarinic (M2 and M3) and purinergic (P2X3) receptors were increased in the MetS, the MetS + OVX and the MetS + OVX + EGCG groups. The gene discussed is P2RX3; the disease is metabolic syndrome.